Nearly 50 years of pulse-processing heritage. Three facilities across North America. Premium lentils, peas and plant proteins exported to more than 35 countries, feeding people and pets around the world.
✦ Q2 2026 results: gross profit up 74%, revenue returns to growth →
Q2 2026 extends the momentum: revenue back to year-over-year growth, gross profit up 74%, and cash building, all in the Company's seasonally slowest half.
Revenue growth to $11.04M from $9.73M in Q2 2025, a return to year-over-year growth.
Gross profit of $1.62M, up from $926,825, with margin expanding to 14.6% from 9.5%.
Positive operating cash flow in the first half of 2026.
Cash at quarter end, up from $5.99M at March 31, 2026.
See the Q2 2026 news release and the interim filings on SEDAR+ for complete results.
Founded in 1978 and 100% owned by Eat Well Group, Belle Pulses transforms yellow and green peas into clean-label whole foods and functional ingredients trusted by global food brands.
A leading agribusiness platform capturing the value chain from farm to market, anchored by 3,000+ farmer relationships in a politically stable, geographically advantaged region.
Demonstrated scale and distribution across 35+ countries, serving world-class B2B customers including Nestlé, General Mills and Ingredion.
Positioned in the $449B food-ingredients market and heavily indexed to its fastest-growing segment: plant protein, projected to reach $162B by 2030.
Pulses are shelf-stable, water-efficient and soil-enriching, directly in the path of government policy momentum on both sides of the border, including billions earmarked for sustainable agriculture.
A leadership team of proven operators who conceived, built and sold Verdient Foods to Ingredion (NYSE: INGR), and have helped raise over $250M across ag, wellness and CPG.
Insiders, management and employees hold 49.4% of the company on a fully diluted basis. When shareholders win, we win.
Our ambition is straightforward: take Belle's winning model and replicate it at scale, becoming the number-one pulse processor in North America.
Three high-capacity facilities, each with expansion-ready land to scale production.
Active expansion into Europe, Asia and South America to meet rising international demand.
Decades of proprietary seed genetics, trade secrets and processing IP, a moat that commands premium pricing.
Category-leading innovation across human and pet food, unlocking premium product lines.
High-impact acquisitions at sector inflection points: scalable platforms with resilient margins.
Gross profit up 74%, gross margin climbs to 14.6% from 9.5%, and revenue returns to growth in the seasonally slowest half.
Read the release → August 5, 2026CEO Daniel Brody's first letter to shareholders: the protein tailwind, the capacity opportunity, and the four metrics he manages to.
Read the letter → July 29, 2026Effective immediately, the Company's common shares have been reinstated for trading on the CSE under the symbol "EWG".
Read the release →Join Eat Well's investor mailing list for financial results, regulatory milestones and operational updates, straight from the company.